JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG
Vol 58(2024) N 1 p. 71-80; DOI 10.1134/S0026893324010035 Full Text

E.A. Filippova1*, V.I. Loginov1, S.S. Lukina1, A.M. Burdennyy1, I.V. Pronina1, T.P. Kazubskaya2, E.A. Braga1

A Group of New Hypermethylated Long Non-Coding RNA Genes Associated with the Development and Progression of Breast Cancer

1Institute of General Pathology and Pathophysiology, Moscow, 125315 Russia
2Blokhin National Medical Research Center of Oncology, Moscow, 115478 Russia

*p.lenyxa@yandex.ru
Received - 2023-05-10; Revised - 2023-08-30; Accepted - 2023-08-30

Breast cancer is the most common type of cancer among women. The study of the mechanisms of metastasis, the main cause of death from breast cancer, as well as the search for new markers for early diagnosis and prognosis of breast cancer, is an extremely topical issue. New perspectives in the diagnosis and treatment of breast cancer are opened by the mechanisms of gene regulation involving non-coding RNAs, in particular, long non-coding RNAs (lncRNAs). In this work, we analyzed the methylation levels of seven lncRNA genes (MEG3, SEMA3B-AS1, HAND2-AS1, KCNK15-AS1, ZNF667-AS1, MAGI2-AS3, and PLUT) by quantitative methyl-specific PCR on a set of 79 paired (tumor/normal) samples of breast cancer. Hypermethylation of all seven lncRNA genes was revealed, and hypermethylation of HAND2-AS1, KCNK15-AS1, MAGI2-AS3, and PLUT was detected in breast cancer for the first time. It was found that the level of meth ylation of the studied lncRNA genes correlated statistically significantly with the stage of the tumor process, the size of the tumor, and the presence of metastases in the lymph nodes. Thus, methylation of the seven studied lncRNA genes is associated with the development and progression of breast cancer, and these genes can be useful as potential markers in the diagnosis and prognosis of breast cancer.

long non-coding RNA genes, DNA methylation, breast cancer



JMB-FOOTER RAS-JOURNALS